Adding Daratumumab to RVd Improves MRD Negativity, PFS in Newly Diagnosed Myeloma
Cesar Rodriguez, MD, discusses his study at ASCO finding that adding daratumumab to RVd improves MRD negativity and PFS in newly diagnosed myeloma.
Cesar Rodriguez, MD, discusses his study at ASCO finding that adding daratumumab to RVd improves MRD negativity and PFS in newly diagnosed myeloma.